Antihuman immunodeficiency virus type 1 (HIV-1) activity of rare earth metal complexes of 4-hydroxycoumarins in cell culture

Bioinorganic Chemistry and Applications

Volumn 2006, Issue , 2006, Pages

  Manolov, Ilia ^a   Raleva, Sevda ^b   Genova, Petya ^b   Savov, Alexey ^a   Froloshka, Liliana ^b   Dundarova, Daniela ^b   Argirova, Radka ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645546661     PISSN: 15653633     EISSN: 1687479X     Source Type: Journal    
DOI: 10.1155/BCA/2006/71938     Document Type: Article

References (18)

1. Zhou P, Takaishi Y, Duan H, et al. Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release. Phytochemistry. 2000;53(6):689-697.
2. Kostova I, Raleva S, Genova P, Argirova R. Recent advances in the discovery and development of plant-derived natural coumarins and their analogues as anti human immunodeficiency virus-type 1 (HIV-1) agents. Biotechnology and Biotechnological Equipment. 2005;19(1):16-22.
3. Shao X, Ekstrand DHL, Bhikhabhai R, Kallander CFR, Gronowitz JS. A non-radioactive microtiter plate reverse transcriptase (RT) assay, based on immobilized template, for screening of RT activity inhibitors and evaluation of their mofe of action. Antiviral Chemistry & Chemotherapy. 1997;8(2):149-159.
4. Thaisrivongs S, Watenpaugh KD, Howe WJ, et al. Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. Journal of Medicinal Chemistry. 1995;38(18):3624-3637.
5. Spino C, Dodier M, Sotheeswaran S. Anti-HIV coumarins from Calophyllum seed oil. Bioorganic & Medicinal Chemistry Letters. 1998;8(24):3475-3478.
6. Xu ZQ, Kern ER, Westbrook L, et al. Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus. Antiviral Chemistry & Chemotherapy. 2000;11(1):23-29.
7. Kashman Y, Gustafson KR, Fuller RW, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Journal of Medicinal Chemistry. 1992;35(15):2735-2743.
8. Mazumder A, Wang S, Neamati N, et al. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Journal of Medicinal Chemistry. 1996;39(13):2472-2481.
9. Rosskopf F, Kraus J, Franz G. Immunological and antitumor effects of coumarin and some derivatives. Die Pharmazie. 1992;47(2):139-142.
10. McCulloch P, George WD. Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth. British Journal of Cancer. 1989;59(2):179-183.
11. Kostova I, Manolov I, Konstantinov S, Karaivanova M. Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts. European Journal of Medicinal Chemistry. 1999;34(1):63-68.
12. Kostova IP, Manolov II, Nicolova IN, Danchev ND. New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity. Il Farmaco. 2001;56(9):707-713.
13. Kostova I, Manolov I, Nicolova I, Konstantinov S, Karaivanova M. New lanthanide complexes of 4-methyl-7-hydroxy-coumarin and their pharmacological activity. European Journal of Medicinal Chemistry. 2001;36(4):339-347.
14. Manolov I, Kostova I, Konstantinov S, Karaivanova M. Synthesis, physicochemical characterization and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Niffcoumar sodium salt. European Journal of Medicinal Chemistry. 1999;34(10):853-858.
15. Manolov I, Kostova I, Netzeva T, Konstantinov S, Karaivanova M. Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands. Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry. 2000;333(4):93-98.
16. Montefiori DC, Robinson WE Jr, Schuffman SS, Mitchell WM. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. Journal of Clinical Microbiology. 1988;26(2):231-235.
17. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 1990;61(2):213-222.
18. Hazuda DJ, Felock P, Witmer M, et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 2000;287(5453):646-650.